Dariush Mozaffarian, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Acasti Pharma (ended)(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: Calibrate and HumanCo(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: UpToDate, royalties for online chapters(MODEST) RESEARCH/RESEARCH GRANTS: National Institutes of Health(SIGNIFICANT), The Rockefeller Foundation(SIGNIFICANT), Kaiser Permanente Fund(SIGNIFICANT), National Association of Chain Drug Stores Foundation(SIGNIFICANT), Gates Foundation(SIGNIFICANT), About Fresh, American Diabetes Association, American Heart Association, Kroger, and family foundations.(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Beren Therapeutics, Brightseed, Calibrate, Elysium Health, Filtricine, HumanCo, Instacart Health, January Inc., Season Health, Validation Institute, WndrHLTH (ended: Perfect Day, Tiny Organics)(SIGNIFICANT), Google(SIGNIFICANT)

View Full Disclosure